Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

FDA approves Santen's Alamast for prevention of itchy eyes due to allergic conjunctivitis

Sep. 27, 1999

InSite expands genetic research program for glaucoma

Sep. 22, 1999

Allergan enters marketing agreement with McNeil for ophthalmic ofloxacin

Sep. 17, 1999

Ciba Vision and QLT initiate T-IND clinical program for Visudyne therapy

Sep. 14, 1999

InSite Vision receives milestone payment for ISV-205 development

Sep. 9, 1999

Cambridge Antibody Technology reports positive initial results from CAT-152 trial

Sep. 7, 1999

NOS-2 inhibition with aminoguanidine prevents vision loss in rat model of glaucoma

Sep. 6, 1999

KeraVision receives FDA approval to complete enrollment for phase IIIb Intacs trial

Sep. 1, 1999

Alcon introduces ocular antiinflammatory agent in Germany

Aug. 27, 1999

Alcon suspends distribution of ophthalmic NSAIDs

Aug. 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...